Matches in Nanopublications for { ?s ?p "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP1013775.RACKabJcZIepSNNgFxnh4YKYb0tVzIArdVI42qvJz24W8130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013775.RACKabJcZIepSNNgFxnh4YKYb0tVzIArdVI42qvJz24W8130_provenance.
- NP771374.RA0k_QvK9blQPpbFRcFLjNWkbxg2fWev4mp-qUuwfrXPY130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771374.RA0k_QvK9blQPpbFRcFLjNWkbxg2fWev4mp-qUuwfrXPY130_provenance.
- NP771534.RA3fxCqwYIywkuQedqsM4PumxM7AfvSKznTnhdSsGWz-w130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771534.RA3fxCqwYIywkuQedqsM4PumxM7AfvSKznTnhdSsGWz-w130_provenance.
- NP1013774.RAxx_GEKcKdjT-yyojChg9E_dABLXHpYK7sEakimHVyoA130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013774.RAxx_GEKcKdjT-yyojChg9E_dABLXHpYK7sEakimHVyoA130_provenance.
- assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP771604.RAg6jetKFng3JXYtj-hugGa4jO7rS3zXHIb4Nd_UggSiU130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771604.RAg6jetKFng3JXYtj-hugGa4jO7rS3zXHIb4Nd_UggSiU130_provenance.
- NP772859.RAm7UJE3KtyzCSHOhUpPdJdSP0Nqt8PaLL216tVK98V3k130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772859.RAm7UJE3KtyzCSHOhUpPdJdSP0Nqt8PaLL216tVK98V3k130_provenance.
- NP1013773.RAiMZJg4wEsaWor6-rvkL2rAGRpPJeFu2uB-oweTRigpE130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013773.RAiMZJg4wEsaWor6-rvkL2rAGRpPJeFu2uB-oweTRigpE130_provenance.
- NP1013777.RAkadgr1-Q8lB5Zc3r2haHpYnwDxDB8Yb8jyzYNgL64y4130_assertion description "[Subgroup analysis reveals that VEGF overexpression is a significant poor predictor for nasopharyngeal cancer (HR, 1.66; 95% CI, 1.30-2.12) and salivary gland cancer (HR, 3.32; 95% CI, 1.61-6.84).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013777.RAkadgr1-Q8lB5Zc3r2haHpYnwDxDB8Yb8jyzYNgL64y4130_provenance.